{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:47Z","timestamp":1786119587470,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/adm.0b013e31820e13dd","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T03:03:40Z","timestamp":1297393420000},"page":"214-220","source":"Crossref","is-referenced-by-count":16,"title":["Low Risk for Hepatitis C Seroconversion in Methadone Maintenance Treatment"],"prefix":"10.1097","volume":"5","author":[{"given":"Einat","family":"Peles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Rados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Adelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J126v01n04_02","article-title":"Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country.","volume":"1","author":"Adelson","year":"2000","journal-title":"J Maintenance Addict"},{"key":"R2-8-20210126","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF02561531","article-title":"Prevalence of anti-hepatitis A antibodies, hepatitis B viral markers, and anti-hepatitis C antibodies among immigrants from the former USSR who arrived in Israel during 1990-1991.","volume":"27","author":"Almog","year":"1999","journal-title":"Infection"},{"key":"R3-8-20210126","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.1990.03450170079026","article-title":"Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.","volume":"264","author":"Alter","year":"1990","journal-title":"J Am Med Assoc"},{"key":"R4-8-20210126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2893.1995.tb00019.x","article-title":"Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin.","volume":"2","author":"Bar-Shany","year":"1995","journal-title":"J Viral Hepat"},{"key":"R5-8-20210126","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/00002030-199815000-00018","article-title":"Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.","volume":"12","author":"Broers","year":"1998","journal-title":"AIDS"},{"key":"R6-8-20210126","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1053\/jlts.2003.50244","article-title":"Scope of worldwide hepatitis C problem.","volume":"9","author":"Brown","year":"2003","journal-title":"Liver Transpl"},{"key":"R7-8-20210126","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/aje\/kwh061","article-title":"Incidence of hepatitis C virus infection and associated risk factors among Scottish prison inmates: a cohort study.","volume":"159","author":"Champion","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R8-8-20210126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10826080902864894","article-title":"Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.","volume":"45","author":"Cohen-Moreno","year":"2010","journal-title":"Subst Use Misuse"},{"key":"R9-8-20210126","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1360-0443.2005.01050.x","article-title":"Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.","volume":"100","author":"Dolan","year":"2005","journal-title":"Addiction"},{"key":"R10-8-20210126","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10654-009-9421-0","article-title":"Incidence and risk for acute hepatitis C infection during imprisonment in Australia.","volume":"25","author":"Dolan","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R11-8-20210126","first-page":"1","article-title":"NIH Consensus S","volume":"15","year":"1997","journal-title":"tatement"},{"key":"R12-8-20210126","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004836-199701000-00006","article-title":"Very high prevalence of hepatitis B and C in Bukharian Jewish immigrants to Israel.","volume":"24","author":"Glikberg","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"R13-8-20210126","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1086\/649783","article-title":"Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities.","volume":"201","author":"Hagan","year":"2010","journal-title":"J Infect Dis"},{"key":"R14-8-20210126","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","article-title":"Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion.","volume":"15","author":"Hagan","year":"2004","journal-title":"Epidemiology"},{"key":"R15-8-20210126","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1467-842X.2004.tb00050.x","article-title":"Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.","volume":"28","author":"Hallinan","year":"2004","journal-title":"Aust N Z J Public Health"},{"key":"R16-8-20210126","first-page":"30","article-title":"Analytical methodology.","volume":"73","author":"Hawks","year":"1986","journal-title":"NIDA Res Monogr"},{"key":"R17-8-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.510260338","article-title":"Hepatitis C virus: epidemiology and transmission.","volume":"26","author":"Heintges","year":"1997","journal-title":"Hepatology"},{"key":"R18-8-20210126","first-page":"775","article-title":"Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.","volume":"10","author":"Loebstein","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"R19-8-20210126","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"key":"R20-8-20210126","first-page":"30","article-title":"High hepatitis C incidence in new injecting drug users: a policy failure Aust N Z J Public H","volume":"31","author":"Maher","year":"2007","journal-title":"ealth"},{"key":"R21-8-20210126","first-page":"217","article-title":"The Addiction Severity Index in three different populations.","volume":"55","author":"McLellan","year":"1984","journal-title":"NIDA Res Monogr"},{"key":"R22-8-20210126","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1360-0443.2008.02188.x","article-title":"Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients review.","volume":"103","author":"Novick","year":"2008","journal-title":"Addiction"},{"key":"R23-8-20210126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10550880802324382","article-title":"One-year and cumulative retention as predictors of success in methadone maintenance treatment: a comparison of two clinics in the United States and Israel.","volume":"27","author":"Peles","year":"2008","journal-title":"J Addict Dis"},{"key":"R24-8-20210126","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1080\/10826080701212550","article-title":"Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in Israel.","volume":"42","author":"Peles","year":"2007","journal-title":"Subst Use Misuse"},{"key":"R25-8-20210126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.09.004","article-title":"Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.","volume":"82","author":"Peles","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R26-8-20210126","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","article-title":"15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.","volume":"107","author":"Peles","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"R27-8-20210126","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.aids.0000304695.54884.4f","article-title":"Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.","volume":"8","author":"Ruan","year":"2007","journal-title":"AIDS"},{"key":"R28-8-20210126","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1467-842X.1997.tb01664.x","article-title":"Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus.","volume":"21","author":"Selvey","year":"1997","journal-title":"Aust N Z J Public Health"},{"key":"R29-8-20210126","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/501858","article-title":"Hepatitis C virus infection in employees of a large university hospital in Israel.","volume":"22","author":"Sermoneta-Gertel","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R30-8-20210126","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Amsterdam. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ADM.0b013e31820e13dd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:55:13Z","timestamp":1786042513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01271255-201109000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e31820e13dd","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13271999.14628086","asserted-by":"object"}]},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}